HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A M Sharma Selected Research

sibutramine (Meridia)

5/2015Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial.
9/2014Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease.
3/2014Association of anemia with the risk of cardiovascular adverse events in overweight/obese patients.
9/2012Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.
6/2012Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.
1/2010Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.
3/2009Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
11/2006Reduced left ventricular mass after treatment of obese patients with sibutramine: An echocardiographic multicentre study.
5/2005Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials.
12/2001Sibutramine in overweight/obese hypertensive patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


A M Sharma Research Topics

Disease

15Hypertension (High Blood Pressure)
06/2008 - 01/2000
13Obesity
03/2014 - 02/2000
10Weight Loss (Weight Reduction)
05/2015 - 04/2001
9Overweight
05/2015 - 12/2001
5Body Weight (Weight, Body)
01/2010 - 09/2004
3Weight Gain
11/2001 - 09/2000
2Inflammation
03/2014 - 04/2003
2Cardiovascular Diseases (Cardiovascular Disease)
09/2012 - 06/2012
2Type 2 Diabetes Mellitus (MODY)
06/2012 - 01/2010
2Diabetes Mellitus
05/2006 - 09/2000
2Insulin Resistance
01/2006 - 04/2001
1Stroke (Strokes)
03/2014
1Anemia
03/2014
1Myocardial Infarction
03/2014
1Heart Arrest (Cardiac Arrest)
03/2014
1Knee Osteoarthritis
12/2011
1Kidney Diseases (Kidney Disease)
04/2005
1Necrosis
04/2005
1Coronary Disease (Coronary Heart Disease)
04/2004
1Cardiac Sudden Death (Sudden Cardiac Arrest)
05/2001
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
05/2001
1Heart Failure
05/2001
1Abdominal Obesity
10/2000
1Fibrosis (Cirrhosis)
06/2000
1Pre-Eclampsia (Preeclampsia)
02/2000

Drug/Important Bio-Agent (IBA)

10sibutramine (Meridia)FDA Link
05/2015 - 12/2001
5Insulin (Novolin)FDA Link
01/2010 - 04/2001
5SodiumIBA
04/2001 - 03/2000
4Glucose (Dextrose)FDA LinkGeneric
09/2012 - 10/2000
3Carbon MonoxideIBA
01/2010 - 04/2004
3Antihypertensive Agents (Antihypertensives)IBA
05/2001 - 03/2000
2CreatinineIBA
03/2014 - 03/2000
2LeptinIBA
04/2005 - 11/2000
2Interleukin-6 (Interleukin 6)IBA
04/2005 - 04/2003
2Anti-Obesity Agents (Antiobesity Drugs)IBA
05/2001 - 04/2001
2First StepIBA
05/2001 - 04/2001
2GTP-Binding Proteins (G-Protein)IBA
09/2000 - 07/2000
1bipiperidyl mustard (BPM)IBA
05/2015
1Hemoglobins (Hemoglobin)IBA
03/2014
1IronIBA
03/2014
1Hydrocortisone (Cortisol)FDA LinkGeneric
06/2008
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2006
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
05/2005
1Norepinephrine (Noradrenaline)FDA LinkGeneric
05/2005
1Serotonin (5 Hydroxytryptamine)IBA
05/2005
1telmisartan (Micardis)FDA Link
04/2005
1Angiotensin Receptors (Angiotensin II Receptor)IBA
04/2005
1Angiotensin IIIBA
04/2005
1AdiponectinIBA
04/2005
1moxonidine (Moxon)IBA
09/2004
1irbesartanFDA LinkGeneric
08/2004
1Protein Kinase CIBA
04/2003
1C-Reactive ProteinIBA
04/2003
1LipidsIBA
11/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2001
1Genetic Markers (Genetic Marker)IBA
04/2001
1Adrenergic Receptors (Adrenergic Receptor)IBA
02/2001
1Natriuretic PeptidesIBA
01/2001
1HormonesIBA
11/2000
1Arginine (L-Arginine)FDA Link
09/2000
1Tryptophan (L-Tryptophan)FDA Link
09/2000
1Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA
07/2000
1Protons (Proton)IBA
07/2000
1ReninIBA
06/2000
1AngiotensinsIBA
06/2000
1Biological Markers (Surrogate Marker)IBA
03/2000
1AngiotensinogenIBA
02/2000
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
01/2000
1Losartan (Cozaar)FDA LinkGeneric
01/2000
1MibefradilIBA
01/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
08/2003 - 05/2001
2Transplants (Transplant)
01/2001 - 03/2000
1Caloric Restriction
06/2013
1Bariatric Surgery
12/2011
1Therapeutics
08/2011
1Gastric Bypass (Roux-en-Y Gastric Bypass)
08/2011
1Homologous Transplantation (Allograft)
03/2000